1,720,972 research outputs found
Supplementary table 2 Article Inclusion and Exclusion -Supplemental material for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies
No full textSupplemental material, Supplementary table 2 Article Inclusion and Exclusion for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies by Sam Maleki, Marliese Alexander, Tsien Fua, Chen Liu, Danny Rischin and Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
Supplementary table 1 -Supplemental material for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies
No full textSupplemental material, Supplementary table 1 for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies by Sam Maleki, Marliese Alexander, Tsien Fua, Chen Liu, Danny Rischin and Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
Supplemental material for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies
No full textSupplemental material for A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies by Sam Maleki, Marliese Alexander, Tsien Fua, Chen Liu, Danny Rischin and Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
sj-docx-1-opp-10.1177_10781552231167554 - Supplemental material for Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists
No full textSupplemental material, sj-docx-1-opp-10.1177_10781552231167554 for Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists by Sarah Glewis, Senthil Lingaratnam, Mei Krishnasamy, Jennifer H Martin, Jeanne Tie, Marliese Alexander and Michael Michael in Journal of Oncology Pharmacy Practice</p
sj-xlsx-1-opp-10.1177_10781552231180875 - Supplemental material for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
No full textSupplemental material, sj-xlsx-1-opp-10.1177_10781552231180875 for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis by Marliese Alexander, Kim Jachno, Kelly-Anne Phillips and
John F Seymour, Monica A Slavin, Ada Cheung, Vivian Shen, Dana Maarouf, Rory Wolfe, Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
sj-xlsx-3-opp-10.1177_10781552231180875 - Supplemental material for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
No full textSupplemental material, sj-xlsx-3-opp-10.1177_10781552231180875 for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis by Marliese Alexander, Kim Jachno, Kelly-Anne Phillips and
John F Seymour, Monica A Slavin, Ada Cheung, Vivian Shen, Dana Maarouf, Rory Wolfe, Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
sj-docx-6-opp-10.1177_10781552231180875 - Supplemental material for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
No full textSupplemental material, sj-docx-6-opp-10.1177_10781552231180875 for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis by Marliese Alexander, Kim Jachno, Kelly-Anne Phillips and
John F Seymour, Monica A Slavin, Ada Cheung, Vivian Shen, Dana Maarouf, Rory Wolfe, Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
sj-xlsx-4-opp-10.1177_10781552231180875 - Supplemental material for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
No full textSupplemental material, sj-xlsx-4-opp-10.1177_10781552231180875 for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis by Marliese Alexander, Kim Jachno, Kelly-Anne Phillips and
John F Seymour, Monica A Slavin, Ada Cheung, Vivian Shen, Dana Maarouf, Rory Wolfe, Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
sj-xlsx-2-opp-10.1177_10781552231180875 - Supplemental material for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
No full textSupplemental material, sj-xlsx-2-opp-10.1177_10781552231180875 for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis by Marliese Alexander, Kim Jachno, Kelly-Anne Phillips and
John F Seymour, Monica A Slavin, Ada Cheung, Vivian Shen, Dana Maarouf, Rory Wolfe, Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
sj-xlsx-5-opp-10.1177_10781552231180875 - Supplemental material for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
No full textSupplemental material, sj-xlsx-5-opp-10.1177_10781552231180875 for Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis by Marliese Alexander, Kim Jachno, Kelly-Anne Phillips and
John F Seymour, Monica A Slavin, Ada Cheung, Vivian Shen, Dana Maarouf, Rory Wolfe, Senthil Lingaratnam in Journal of Oncology Pharmacy Practice</p
- …
